Drug Database
Back to search

France· FR:68928009

KEAL 1 g, suspension buvable en sachet

A sucralfate product containing sucralfate, registered in France by EXOD. The same ATC class is registered in 13 of our 19 countries.

ATC A02BX02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedKEAL 1 g, suspension buvable en sachetATCA02BX02REGISTER NO.FR:68928009PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sucralfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sucralfate is registered in 13 of 19 countries.

Countries holding a registration under ATC A02BX02 (sucralfate), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search sucralfate products by name

Sucralfate · ATC A02BX02

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sucralfate costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sucralfate · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • IT Italy$0.62
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SUCRALFATE
Manufacturer
EXOD
Country
France (FR)
ATC code
A02BX02
ATC class
Sucralfate
Defined daily dose
4 g, O
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400933397562
    30 sachet(s) aluminium polyéthylène papier de 5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

504 interactions on record for sucralfate.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sucralfate against other medicinesHow interaction checks work

Sucralfate · interactions on record

504 records

  • 5 severe
  • 116 moderate
  • 46 minor
  • 337 info

Most severe, free to view

  • ParicalcitolA11CC07severe
  • ParicalcitolH05BX02severe
  • DoxercalciferolH05BX03severe
  • DolutegravirJ05AJ03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sucralfate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sucralfate products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Sucralan, Sucralfat Genericon
  • Germany · Sucrabest
  • Denmark · Antepsin, Peptonorm
  • Finland · Antepsin, Peptonorm
  • United Kingdom (Northern Ireland) · Sucralfate Roma Pharmaceuticals
  • Greece · Peptonorm
  • Hungary · Peptonorm
  • Iceland · Antepsin
  • Italy · Antepsin, Sucralfato Doc Generici
  • Netherlands · Sucralfaat Sandoz, Sucralfaat Teva
  • Norway · Antepsin
  • Portugal · Sucralfato Generis, Sucralfato Jaba
  • Sweden · Andapsin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9fdf0d41-a06b-4435-82e5-2bd90590cd1a
GET /v1/drugs/9fdf0d41-a06b-4435-82e5-2bd90590cd1a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68928009",
  "date_amm": "1991-06-24",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "SUCRALFATE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about sucralfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console